Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study
Jazyk angličtina Země Nový Zéland Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- benzodiazepiny terapeutické užití MeSH
- hospitalizace statistika a číselné údaje MeSH
- hypnotika a sedativa terapeutické užití MeSH
- incidence MeSH
- lidé MeSH
- prospektivní studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- úrazy pádem statistika a číselné údaje MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Austrálie epidemiologie MeSH
- Názvy látek
- benzodiazepiny MeSH
- hypnotika a sedativa MeSH
BACKGROUND: Hypnosedatives are commonly prescribed for anxiety and sleep problems. Changes in pharmacokinetics and pharmacodynamics of benzodiazepines (BZDs) during ageing may increase their potential to cause adverse outcomes. OBJECTIVE: This study aimed to investigate the use of BZDs in acute care settings and explore their association with falls. METHODS: A prospective cohort study was undertaken of patients aged over 70 years consecutively admitted to 11 acute care hospitals in Australia. Data were collected using the interRAI Acute Care assessment tool. Falls were recorded prospectively (in hospital) and retrospectively (in the 90 days prior to admission). RESULTS: Of 1,412 patients, 146 (10.3 %) were taking BZDs at admission and 155 (11.3 %) at discharge. Incidence rates of in-hospital fallers for users and non-users of BZDs were not statistically different [incidence rate ratio 1.03, 95 % confidence interval (CI) 0.58-1.82]. There was also no significant association between benzodiazepine use at admission and history of falls in the previous 90 days compared with non-users. However, patients on diazepam were significantly more likely to have a history of falls than all other benzodiazepine users (70.8 vs. 36.1 %; p = 0.002), particularly when compared with oxazepam users (70.8 vs. 25.0 %; p < 0.001). Adjusting for confounders, use of diazepam at admission was positively associated with a history of falls compared with all other benzodiazepine users (odds ratio 3.0; 95 % CI 1.1-8.5; p = 0.036). CONCLUSIONS: Different BZDs may vary in their propensity to predispose to falls, with diazepam having the strongest association. The selection of particular BZDs for older patients should be carefully evaluated.
Zobrazit více v PubMed
Am J Geriatr Pharmacother. 2011 Dec;9(6):378-91 PubMed
Arch Intern Med. 1995 Sep 11;155(16):1801-7 PubMed
Drugs Aging. 2008;25(1):61-70 PubMed
Am J Geriatr Pharmacother. 2007 Sep;5(3):263-303 PubMed
Arch Intern Med. 2003 Dec 8-22;163(22):2716-24 PubMed
Age Ageing. 2004 Mar;33(2):122-30 PubMed
Ann Intern Med. 1994 Sep 15;121(6):442-51 PubMed
Drugs Aging. 2013 Apr;30(4):247-54 PubMed
Can J Aging. 2010 Jun;29(2):205-13 PubMed
Accid Anal Prev. 2000 May;32(3):371-2 PubMed
Dement Geriatr Cogn Disord. 2009;27(6):557-63 PubMed
Br J Gen Pract. 2011 Sep;61(590):e573-8 PubMed
CNS Drugs. 2004;18(1):37-48 PubMed
J Aging Health. 2011 Mar;23(2):329-46 PubMed
J Am Geriatr Soc. 2002 Oct;50(10):1629-37 PubMed
Drugs Aging. 2009;26(2):113-22 PubMed
Dtsch Arztebl Int. 2010 Aug;107(31-32):543-51 PubMed
J Gerontol A Biol Sci Med Sci. 2012 Feb;67(2):175-80 PubMed
Am J Geriatr Pharmacother. 2004 Dec;2(4):274-302 PubMed
Eur J Clin Pharmacol. 2007 Aug;63(8):725-31 PubMed
BMC Public Health. 2010 Jul 06;10:396 PubMed
J Am Geriatr Soc. 2003 Jun;51(6):841-6 PubMed
J Am Geriatr Soc. 2005 Feb;53(2):233-41 PubMed
Clin Geriatr Med. 2012 May;28(2):273-86 PubMed
Clin Pharmacokinet. 1998 Jul;35(1):49-64 PubMed
Age Ageing. 2011 Jan;40(1):23-9 PubMed
Postgrad Med J. 2002 Aug;78(922):487-9 PubMed
J Am Geriatr Soc. 1999 Jan;47(1):30-9 PubMed
Pharmacol Rev. 2004 Jun;56(2):163-84 PubMed
BMC Health Serv Res. 2011 Oct 20;11:281 PubMed
Scand J Prim Health Care. 2009;27(3):153-9 PubMed
Aust N Z J Public Health. 2000 Feb;24(1):7-10 PubMed
Int J Geriatr Psychiatry. 2011 Jun;26(6):602-7 PubMed
Drugs Aging. 2012 May 1;29(5):359-76 PubMed
J Am Geriatr Soc. 2011 Nov;59(11):2001-8 PubMed
Age Ageing. 2006 May;35(3):246-51 PubMed
J Am Geriatr Soc. 2006 Aug;54(8):1169-76 PubMed
Am J Epidemiol. 1994 Nov 1;140(9):830-8 PubMed
Drugs Aging. 1995 Sep;7(3):184-202 PubMed
J Clin Epidemiol. 2000 Dec;53(12):1222-9 PubMed
BMC Health Serv Res. 2009 Apr 29;9:71 PubMed
Int J Biochem Cell Biol. 2013 Jun;45(6):1121-32 PubMed
Can J Aging. 2011 Mar;30(1):7-19 PubMed
Eur J Clin Pharmacol. 2001 Aug;57(5):419-25 PubMed
Scand J Soc Med. 1997 Mar;25(1):8-13 PubMed
Eur J Clin Pharmacol. 2013 Mar;69(3):319-26 PubMed
N Engl J Med. 1995 Mar 23;332(12):767-73 PubMed
J Am Geriatr Soc. 2000 Jun;48(6):682-5 PubMed
Intern Med J. 2013 Mar;43(3):262-9 PubMed
Clin Pharmacol Ther. 1997 Mar;61(3):331-9 PubMed
BMC Geriatr. 2009 Jul 23;9:30 PubMed
BMC Health Serv Res. 2008 Dec 30;8:277 PubMed
J Am Geriatr Soc. 2001 Oct;49(10):1341-5 PubMed
J Clin Epidemiol. 1997 Jul;50(7):857-63 PubMed
Drugs Aging. 2009;26(10):847-52 PubMed
Fundam Clin Pharmacol. 2007 Jun;21(3):217-30 PubMed
J Am Geriatr Soc. 2008 Mar;56(3):536-41 PubMed
Br J Clin Pharmacol. 2007 Feb;63(2):232-7 PubMed
Drug Metab Rev. 2009;41(2):67-76 PubMed
Arch Intern Med. 2009 Nov 23;169(21):1952-60 PubMed